Application

18015439 · COMBINATIONS OF GABAA ALPHA 5 AGONISTS AND SV2A INHIBITORS AND METHODS OF USING IN THE TREATMENT OF COGNITIVE IMPAIRMENT

Filed 2023-01-10 · Pending The official file ↗ · Art unit 1627 · Examiner Dawanna Shar-Day White Typical · CPC A61P 25/28 · AGENEBIO, INC. · Leason Ellis LLP (Life Sciences)

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

30.7 mo

to disposition n/a

Statutes raised

103 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.